Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/8/2025

TNM Classification and Management of Locally Advanced Breast Carcinoma

Introduction to Locally Advanced Disease

  • Locally advanced breast carcinoma corresponds to Stage III disease in the TNM staging system, which encompasses T3N1M0, as well as T4 tumors with any N status, or any T with N2-N3 nodal involvement, all without distant metastases, as defined by the National Comprehensive Cancer Network (NCCN) 1, 2, 3

Primary Tumor (T) Classification

  • The T stage for locally advanced breast cancer includes T3, which is a tumor greater than 50 mm in greatest dimension, according to the American Joint Committee on Cancer (AJCC) 1, 2
  • T4a is defined as extension to the chest wall, not including only pectoralis muscle adherence/invasion, as per the AJCC 1, 2
  • T4b includes ulceration and/or ipsilateral satellite nodules and/or edema of the skin, which do not meet criteria for inflammatory carcinoma, based on the AJCC definition 1, 2
  • T4c is both T4a and T4b, as defined by the AJCC 1, 2
  • T4d is inflammatory carcinoma, according to the AJCC 1, 2

Regional Lymph Node (N) Classification

  • N1 is defined as metastases to movable ipsilateral level I, II axillary lymph node(s), as per the AJCC 1, 2
  • N2a includes metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed to one another or to other structures, based on the AJCC definition 1, 2
  • N2b is metastases only in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases, as defined by the AJCC 1, 2
  • N3 includes metastases to ipsilateral infraclavicular nodes, or ipsilateral internal mammary nodes with axillary involvement, or ipsilateral supraclavicular nodes, according to the AJCC and NCCN 1, 2, 4

Stage Groupings for Locally Advanced Disease

  • Stage IIIA includes T3N1M0, T0-2, N2, M0, and T3N2M0, as defined by the NCCN and AJCC 1, 2, 3
  • Stage IIIB includes T4N0-2M0, which is inoperable locally advanced disease, according to the NCCN 3
  • Stage IIIC includes any T, N3, M0, as defined by the NCCN and AJCC 4

Clinical Distinction and Management

  • A critical distinction exists within Stage III disease based on operability, with operable locally advanced disease (T3N1M0) likely to achieve pathologically negative margins and provide long-term local control, and inoperable locally advanced disease requiring neoadjuvant chemotherapy before definitive surgery, as recommended by the NCCN 3

Required Staging Workup for Locally Advanced Disease

  • For patients with locally advanced breast cancer, comprehensive staging must include history and physical examination, complete blood count, platelet count, liver function tests, and alkaline phosphatase, as well as imaging studies such as chest X-ray or CT, abdominal imaging with CT, ultrasound, or MRI, bone scan, and diagnostic bilateral mammogram, according to the NCCN 3, 5
  • Pathology review with ER/PR and HER2 status determination, and genetic counseling if high-risk for hereditary breast cancer, are also essential components of the staging workup, as recommended by the NCCN 3, 5

REFERENCES

3

breast cancer. clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

4

breast cancer: noninvasive and special situations. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

5

NCCN Guidelines for Breast Cancer Staging [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025